Results of an open-label, phase Ia/Ib study of olaratumab plus pembrolizumab in patients with unresectable, locally advanced or metastatic soft tissue sarcoma Meeting Abstract
| Authors: | Schöffski, P.; Bahleda, R.; Wagner, A. J.; Burgess, M.; Junker, N.; Chisamore, M.; Peterson, P.; Ceccarelli, M.; William, T. |
| Abstract Title: | Results of an open-label, phase Ia/Ib study of olaratumab plus pembrolizumab in patients with unresectable, locally advanced or metastatic soft tissue sarcoma |
| Meeting Title: | ESMO Immuno-Oncology Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2021 Dec 8-11 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-12-01 |
| Start Page: | S1447 |
| Language: | English |
| ACCESSION: | WOS:000731051400157 |
| DOI: | 10.1016/j.annonc.2021.10.173 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 154P -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics